Deal overview

Deal overview
Target REGENERON PHARMACEUTICALS INC
Bidder INVESTORS
Price £0.00 Full version or £25.00 Light version
Publication Date May 25, 2020
Abstract On 25 May 2020, the quoted French pharmaceutical company Sanofi SA ("Sanofi") announced its intent to sell its equity investment in Regeneron Pharmaceuticals Inc ("Regeneron"), a US-listed biotechnology company, through a registered public offering and related share repurchase by Regeneron itself. The registered offering would have no impact on the ongoing collaboration ...
Number of pages (Full version) 0
Number of pages (Light version) 2
Format Adobe Acrobat (Download Acrobat Reader)
Free Sample Click Here to Download

Purchase this report

Accepted credit cards: Visa, America Express, Master Card

Buy and download this report in a fast a safe way using our secure payment system. We accept all major credit cards.

Search for Deals

Search over 70 million deal reports on more than 550,000 public and private companies. (copy)

Back to search results

Page Time: 0.025473s